'Consolidated net sales (including other operating income) of Advanced Enzyme Technologies has increased 4.92% to Rs 154.52 crore.  The total revenue from operations grew by 5% on YoY basis and de-grew by 2% on QoQ basis.  The revenue from human nutrition segment increased by 2% to Rs 101.2 crore in Q1FY25 as compared to Rs 99.4 crore in Q1FY24. This growth is on account of Probiotics and Nutrition business. The Animal nutrition delivered a growth of 9% to Rs 17.2 crore in Q1FY25 as against Rs 15.8 crore in Q1FY24. The Bio-Processing segment outperformed by 12% during the quarter and accounted for Rs 25.1 crore in Q1FY25 as compared to Rs 22.4 crore in Q1FY24. In this segment, food business grew by 6% to Rs 19.6 crore on YoY basis during Q1FY25. The Non-Food business grew by 43% to stood at Rs 5.5 crore during the quarter. The specialized manufacturing segment contributed 7% in the pie which is around Rs 11.0 crore to the revenue during the quarter, an...

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation